Further, they also aim to streamline the manufacturing of complex formulations, including fixed dose combinations, orally disintegrating tablets, minitablets, flavored chewables, and double-layered tablets.
The financial opportunity within the oral solid dosage contract manufacturing market has been analyzed across the following segments:
- Type of Finished Dosage Form
- Tablets
- Capsules
- Granules
- Powders
- Others
- Type of Packaging
- Bottles
- Blisters
- Sachets
- Strips
- Stick Packs
- Scale of Operation
- Pre-commercial
- Commercial
- Company Size
- Small
- Mid-sized
- Large
- Very Large
- Therapeutic Areas
- Oncological Disorders
- Cardiovascular Disorders
- Metabolic Disorders
- Neurological Disorders
- Genetic Disorders
- Respiratory Disorders
- Immunological Disorders
- Other Disorders
- Key Geographical Regions
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and North Africa
The Oral Solid Dosage Manufacturing Market, 2023-2035 report also includes profiles of key players (listed below) engaged in manufacturing bioreactors and fermenters; each profile includes a brief overview of the company, along with information on its financial information (if available), product portfolio, recent developments and an informed future outlook.
- Aenova
- Alcami
- Almac
- Cambrex
- Catalent
- Hetero Drugs
- Ind-Swift
- Lonza
- Rubicon Research
Table of Contents
- Preface
2. Executive Summary
Introduction- Oral Solid Dosage Manufacturing Organizations (CMOs): Market Landscape
- Company Competitiveness Analysis
- Regional Capability Analysis
- Company Profiles
- Make vs Buy Decision Framework
- Recent Expansions
- Capacity Analysis
- Demand Analysis
- Total Cost of Ownership for Oral Solid Dosage Contract Manufacturing Organizations
- Regulatory Landscape for Oral Solid Dosage Contract Manufacturers
- Case Study on Taste Masking Services and Technologies: Market Landscape
- Case Study on Bioavailability Enhancement Technologies: Market Landscape
- Market Forecast
- Executive Insights
- Concluding Remarks
- Appendix 1: Tabulated Data
- Appendix 2: List of Companies and Organizations
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/oral-solid-dosage-manufacturing-market.html
You may also be interested in the following titles:
|
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
